Design and Rationale of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES)

被引：0
|
作者：
Pieske, B. [1 ]
Butler, J. [2 ]
Filippatos, G. [3 ]
Lam, C. [4 ]
Maggioni, A. [5 ]
Ponikowski, P. [6 ]
Shah, S. [7 ]
Solomon, S. [8 ]
Roessig, L. [9 ]
Gheorghiade, M.
机构：
[1] Med Univ Graz, Graz, Austria
[2] Emory Univ Hosp, Atlanta, GA 30322 USA
[3] Univ Athens, Athens, Greece
[4] Natl Univ Heart Ctr, Singapore, Singapore
[5] ANMCO Fdn Your Heart, Florence, Italy
[6] Mil Hosp Wroclaw, Wroclaw, Poland
[7] Northwestern Univ, Chicago, IL 60611 USA
[8] Brigham & Womens Hosp, Boston, MA 02115 USA
[9] Bayer Pharma AG, Wuppertal, Germany
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [21] Soluble Guanylate Cyclase Activators and Stimulators in Patients with Heart Failure
    Liang, Wei-Lin
    Liang, Bo
    CURRENT CARDIOLOGY REPORTS, 2023, 25 (06) : 607 - 613
  • [22] Soluble Guanylate Cyclase Activators and Stimulators in Patients with Heart Failure
    Wei-Lin Liang
    Bo Liang
    Current Cardiology Reports, 2023, 25 : 607 - 613
  • [23] Soluble guanylate cyclase: a potential therapeutic target for heart failure
    Mihai Gheorghiade
    Catherine N. Marti
    Hani N. Sabbah
    Lothar Roessig
    Stephen J. Greene
    Michael Böhm
    John C. Burnett
    Umberto Campia
    John G. F. Cleland
    Sean P. Collins
    Gregg C. Fonarow
    Phillip D. Levy
    Marco Metra
    Bertram Pitt
    Piotr Ponikowski
    Naoki Sato
    Adriaan A. Voors
    Johannes-Peter Stasch
    Javed Butler
    Heart Failure Reviews, 2013, 18 : 123 - 134
  • [24] Vericiguat: The First Soluble Guanylate Cyclase Stimulator for Reduction of Cardiovascular Death and Heart Failure Hospitalization in Patients With Heart Failure Reduced Ejection Fraction
    Tran, Bao-Anh
    Serag-Bolos, Erini S.
    Fernandez, Joel
    Miranda, Aimon C.
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (04) : 905 - 914
  • [25] Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction The SOCRATES-REDUCED Randomized Trial
    Gheorghiade, Mihai
    Greene, Stephen J.
    Butler, Javed
    Filippatos, Gerasimos
    Lam, Carolyn S. P.
    Maggioni, Aldo P.
    Ponikowski, Piotr
    Shah, Sanjiv J.
    Solomon, Scott D.
    Kraigher-Krainer, Elisabeth
    Samano, Eliana T.
    Mueller, Katharina
    Roessig, Lothar
    Pieske, Burkert
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (21): : 2251 - 2262
  • [26] Development of vericiguat: The first soluble guanylate cyclase (sGC) stimulator launched for heart failure with reduced ejection fraction (HFrEF)
    Xia, Juan
    Hui, Nan
    Tian, Lei
    Liang, Chengyuan
    Zhang, Jie
    Liu, Jifang
    Wang, Jun
    Ren, Xiaodong
    Xie, Xiaolin
    Wang, Kun
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 149
  • [27] SAFETY AND EFFICACY OF SOLUBLE GUANYLATE CYCLASE STIMULATORS IN PATIENTS WITH HEART FAILURE
    Zghouzi, Mohamed
    Ullah, Waqas
    Ahmad, Bachar
    Sattar, Yasar
    Zaher, Nathan
    Mir, Tanveer
    Elmakshbr, Nada
    Ali, Omar
    Gardi, Delair
    Hakim, Zaher
    Alraies, M. Chadi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 772 - 772
  • [28] Riociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension
    Lian, Tian-Yu
    Jiang, Xin
    Jing, Zhi-Cheng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 1195 - 1207
  • [29] Nonclinical Cardiovascular Assessment of the Soluble Guanylate Cyclase Stimulator Vericiguat
    Himmel, Herbert
    Lagrutta, Armando
    Voemel, Matthias
    Amin, Rupesh P.
    Imredy, John P.
    Johnson, Timothy
    Vinzing, Maya
    Prescott, Judith
    Blaustein, Robert O.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 386 (01): : 26 - 34
  • [30] RIOCIGUAT Soluble Guanylate Cyclase Stimulator Treatment of Pulmonary Hypertension
    Mulligan, C.
    DRUGS OF THE FUTURE, 2009, 34 (06) : 468 - 475
12345